Pre-Open Stock Movers 07/26: (TYME) (MSTR) (FLOW) Higher; (ATIP) (ITRM) (TNXP) Lower (more...)

Hasbro (HAS) Declares $0.68 Quarterly Dividend; 2.7% Yield

Hasbro (NASDAQ: HAS) declared a quarterly dividend of $0.68 per share, or $2.72 annualized.

The dividend will be payable on November 15, 2021, to stockholders of record on November 1, 2021, with an ex-dividend date of October 29, 2021.

The annual yield on the dividend is 2.7 percent.

For a... More

Hasbro (HAS) PT Raised to $128 at DA Davidson

DA Davidson analyst Linda Bolton Weiser raised the price target on Hasbro (NASDAQ: HAS) to $128.00 (from $120.00) while maintaining a Buy rating.

The analyst commented, "HAS closed +12% on a big 2Q21 upside surprise, with sales +54% and +9% vs. 2Q19. HAS still expects double-digit sales... More

Hasbro (HAS) PT Raised to $120 at Jefferies

Jefferies analyst Stephanie Wissink raised the price target on Hasbro (NASDAQ: HAS) to $120.00 (from $115.00) while maintaining a Buy rating.

The analyst commented, "We see Q2 as a hallmark quarter, validating staying the course despite peripheral disruptions to the business. Sales & EBITDA handily... More

Tonix Pharma (TNXP) Acquires Infectious Disease R&D Facility

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) a clinical-stage biopharmaceutical company, today announced the signing of a Purchase and Sale Agreement to acquire an approximately 48,000 square foot research and development (R&D) facility in Frederick, MD to support Tonixs expanding infectious disease pipeline, including TNX-1800, a live replicating viral vaccine designed to protect against COVID-19, TNX-801, a live vaccine designed to protect against smallpox and monkeypox, and TNX-3500, a small molecule antiviral to inhibit replication of SARS-CoV-2.

Tonix agreed to purchase the R&D facility from Southern Research, a research collaboration partner... More